Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Future Virol. 2013 Jan;8(1):81–101. doi: 10.2217/fvl.12.127

Table 1. Neurologic complications associated with aging and HIV-1 infection.

Observation Issues Ref.
Older HIV+ patients display greater neurocognitive
impairment
Utilized large cohorts of HIV+ and
HIV patients, but uninfected control
group was younger than HIV+ group
[116]
Age effects seen in older HIV+ patients as
compared with younger HIV+ patients
Lacked young and old HIV control
groups
[127]
Differential decline in cognitive impairment with
increasing age in HIV+ patients
Sample of older HIV patients was
small
[128]
No significant interaction between age and
neurocognitive impairment
None. Well-controlled study using a
well-established cohort
[129]
Decreased concentrations of N-acetylaspartate in
frontal white matter suggest mitochondrial toxicity
Only looked at four antiretroviral
compounds
[130]
Cardiovascular diseases, including dyslipidemia,
hypertension and diabetes, associated with
neurocognitive impairment in HIV+ patients, and
greater neurocognitive score
[114,115,132]
Diffusion-weighted MRI found an association
between abnormal glucose metabolism and lower
fatty acid in caudate nucleus and hippocampus
Effects were mitigated with age and
education adjustment
[134]